Aug 19, 2022 / Comment Letters

MedPAC comment on CMS’s proposed rule on the ESRD PPS update for CY 2023

Research Areas:

Ambulatory Care Settings, Drugs, Devices, and Tests, Quality

Aug 15, 2022 / Comment Letters

MedPAC comment on CMS’s proposed rule on the home health prospective payment system for CY 2023

Research Areas:

Post-Acute Care, Quality

Jul 27, 2022 / Comment Letters

MedPAC comment on CMS’s proposed rule on conditions of participation (CoPs) for rural emergency hospitals and critical access hospital CoP updates

Research Areas:

Hospitals, Physicians And Other Health Professionals, Regional Issues

Jun 28, 2022 / Congressional Testimony

Testimony: Improving the Medicare Advantage Program (Energy and Commerce)

Research Areas:

Private Plans, Quality

Jun 16, 2022 / Comment Letters

MedPAC comment on CMS’s proposed rule on the hospital inpatient prospective payment system and the long-term care hospital prospective payment system for FY 2023

Research Areas:

Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Reports

June 2022 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Chapters

Executive summary (June 2022 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Chapters

Chapter 7: Segmentation in the stand-alone Part D plan market (June 2022 report)

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests

Jun 15, 2022 / Chapters

Chapter 6: Aligning fee-for-service payment rates across ambulatory settings (June 2022 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Hospitals, Physicians And Other Health Professionals

Jun 15, 2022 / Chapters

Chapter 4: Addressing high prices of drugs covered under Medicare Part B (June 2022 report)

Research Areas:

Drugs, Devices, and Tests